Kathy Khoy
Caen, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Clinical impact of ceruloplasmin levels at ANCA-associated vasculitis diagnosis.
Journal: PloS one
Published: April 02, 2024
Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab.
Journal: BMC cancer
Published: November 02, 2022
Early infectious risk in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis according to remission-induction therapy.
Journal: Scandinavian journal of rheumatology
Published: January 20, 2022
The diagnostic challenge of patients with anti-U1-RNP antibodies.
Journal: Rheumatology international
Published: November 21, 2021
The detection of antithyroid antibodies in cerebrospinal fluid using fluorescent enzyme immuno assay (FEIA) is suitable for biological diagnosis of Hashimoto's encephalopathy
Journal: Annales de biologie clinique
Published: April 05, 2021
Recurrent anaphylaxis to a gelatin-based colloid plasma substitute and to cetuximab following sensitisation to galactose-alpha-1,3-galactose.
Journal: British journal of anaesthesia
Published: November 18, 2020
Mediators of anaphylactic reactions: Tryptase and histamine stability in whole blood.
Journal: Allergy
Published: July 24, 2020
Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring.
Journal: Frontiers in immunology
Published: April 07, 2020
Clinical Effect of Alpha-1 Antitrypsin Deficiency in Antineutrophil Cytoplasmic Antibody-associated Vasculitis: Results from a French Retrospective Monocentric Cohort.
Journal: The Journal of rheumatology
Published: November 12, 2018
Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification.
Journal: Rheumatology (Oxford, England)
Published: October 02, 2018
Last Updated: 09/26/2026